Operational definition of developmental and epileptic encephalopathies to underpin the design of therapeutic trials
Epilepsia · 2025-04 · 66 (4) · 1014-1023
DOI: 10.1111/epi.18265 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Epilepsia, online erschienen am 27.02.2025. Verfasst von Ingrid E Scheffer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Epilepsy Research Centre, Austin Health, The University of Melbourne, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Clinical Trials as Topic, Epilepsy, Epileptic Syndromes, Research Design. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Developmental and epileptic encephalopathies (DEEs) are the most severe group of epilepsies, characterized by drug‐resistant seizures and developmental slowing or regression. DEEs encompass many epilepsy syndromes, although not all patients with a DEE can be classified into a specific syndrome. Our understanding of the etiologies of DEEs has been revolutionized with next‐generation sequencing, with more than 900 genes implicated, in addition to structural causes. It is therefore now possible to consider precision medicine and novel therapeutic approaches for these devastating diseases with trials of repurposed and new drugs, including gene therapies. Trials are being designed to target either DEE diseases more broadly, specific DEE syndromes, or specific genetic DEEs. To serve this purpose, a clear operational definition of DEEs is needed to ensure that appropriate patients are selected for trials with precisely defined, targeted outcome measures. Herein we propose the operational definition of DEEs to set the stage for the development of DEE therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Epilepsy Research Centre, Austin Health, The University of Melbourne, Melbourne, Victoria, Australia.
- Florey and Murdoch Children's Research Institutes, Melbourne, Victoria, Australia.
- Department of Paediatrics, Royal Children's Hospital, The University of Melbourne, Parkville, Victoria, Australia.
- Comprehensive Epilepsy Center, New York University Grossman School of Medicine, New York City, New York, USA.
- Epilepsy Research Center, University of São Paulo Faculty of Medicine, São Paulo, Brazil.
- Pediatric Neurology Department, CRMR Epilepsies Rares, Member of ERN EpiCARE, APHP, Robert Debré University Hospital, Paris, France.
ORCID-Profile: Ingrid E Scheffer, Jacqueline French, Kette D Valente, Stéphane Auvin, J Helen Cross, Nicola Specchio
Zitieren
APA
Scheffer, I. E., French, J., Valente, K. D., Auvin, S., Cross, J. H., & Specchio, N. (2025). Operational definition of developmental and epileptic encephalopathies to underpin the design of therapeutic trials. Epilepsia, 66(4), 1014-1023. https://doi.org/10.1111/epi.18265
Vancouver
Scheffer IE, French J, Valente KD, Auvin S, Cross JH, Specchio N. Operational definition of developmental and epileptic encephalopathies to underpin the design of therapeutic trials. Epilepsia. 2025;66(4):1014-1023. doi:10.1111/epi.18265
BibTeX
@article{Scheffer2025,
author = {Scheffer, Ingrid E and French, Jacqueline and Valente, Kette D and Auvin, Stéphane and Cross, J Helen and Specchio, Nicola},
title = {Operational definition of developmental and epileptic encephalopathies to underpin the design of therapeutic trials},
journal = {Epilepsia},
year = {2025},
volume = {66},
number = {4},
pages = {1014--1023},
doi = {10.1111/epi.18265}
}
EUVIMED